Mirxes觅瑞通过港交所上市聆讯

Core Viewpoint - Mirxes Holding Company Limited is seeking to go public through a listing hearing on the Hong Kong Stock Exchange, with CICC and Jianyin International as joint sponsors [1] Company Overview - Mirxes was established in 2014 and is headquartered in Singapore [1] - The company specializes in microRNA (miRNA) technology [1] Product Information - The core product of Mirxes is GASTROClearTM, a blood-based miRNA testing kit for gastric cancer screening [1] - GASTROClearTM consists of 12 miRNA biomarkers [1]